Daniël Splinter

Daniël Splinter is a seasoned professional in bioanalytics and immunology with extensive experience in various leadership roles across prominent companies. Currently serving as Principal Scientist in Bioanalytics at argenx since April 2020, Daniël previously held positions at Sanquin as Head of Biologics and Immunomonitoring Laboratories, and at Philip Morris International as QA Project Lead. Notably, at The Janssen Pharmaceutical Companies of Johnson & Johnson, Daniël led significant projects including a multivalent Ebola vaccine. With a comprehensive background in biomarker and biopharmaceutical studies from Eurofins Global Central Laboratory, and a solid academic foundation with a PhD in Cell Biology from Leiden University, Daniël showcases a robust skill set in scientific research and project management.